Counterpoint: animal tumor models and their relevance to human tumor immunology

Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

Cancer research·1992

The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Cancer research·1992

Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.

Journal of immunology (Baltimore, Md. : 1950)·1992

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

International journal of cancer·1992

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Journal of immunology (Baltimore, Md. : 1950)·1992

Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration.

Natural immunity·1992

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

Journal of biological response modifiers·1990

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.

Journal of biological response modifiers·1990

Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.

Journal of biological response modifiers·1990

Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.

Journal of biological response modifiers·1990

Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.

Journal of biological response modifiers·1990

Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.

Journal of biological response modifiers·1990

Locally Aggressive Breast Desmoid Fibromatosis in a Young Woman With Multiple Fibroadenomas.

International journal of surgical pathology·2026

Tebentafusp desensitization in an adult with metastatic uveal melanoma.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Expression of V‑domain Ig suppressor of T cell activation in ovarian cancer and its regulation of follicular regulatory T‑cell function via the AKT/MAPK pathway.

Oncology reports·2026

Adjuvant immunotherapy versus observation after neoadjuvant therapy and esophagectomy for esophageal cancer with residual pathologic disease: a systematic review and reconstructed individual participant data meta-analysis.

Frontiers in immunology·2026

Small intestine intussusception causing intestinal obstruction secondary to left pinna melanoma metastases: a case report.

Frontiers in surgery·2026

A malignancy risk prediction model for Bethesda category III thyroid nodules based on serological indicators, C-TIRADS, and BRAF V600E testing.

Frontiers in endocrinology·2026

Related Experiment Videos

Counterpoint: animal tumor models and their relevance to human tumor immunology

Related Concept Videos

Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration.

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.

Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.

Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.

Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.

Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.

Locally Aggressive Breast Desmoid Fibromatosis in a Young Woman With Multiple Fibroadenomas.

Tebentafusp desensitization in an adult with metastatic uveal melanoma.

Expression of V‑domain Ig suppressor of T cell activation in ovarian cancer and its regulation of follicular regulatory T‑cell function via the AKT/MAPK pathway.

Adjuvant immunotherapy versus observation after neoadjuvant therapy and esophagectomy for esophageal cancer with residual pathologic disease: a systematic review and reconstructed individual participant data meta-analysis.

Small intestine intussusception causing intestinal obstruction secondary to left pinna melanoma metastases: a case report.

A malignancy risk prediction model for Bethesda category III thyroid nodules based on serological indicators, C-TIRADS, and BRAF V600E testing.

Related Experiment Videos

Counterpoint: animal tumor models and their relevance to human tumor immunology

Related Concept Videos

Related Articles